Information Journal Paper
APA:
CopyBROCK, B., & SMIDT, K.. (2005). IS METFONNIN THERAPY FOR POLYCYSTIC OVARY SYNDROME SAFE DURING PREGNANCY?. BASIC CLINICAL PHARMACOLOGY AND TOXICOLOGY, 96(6), 410-412. SID. https://sid.ir/paper/655843/en
Vancouver:
CopyBROCK B., SMIDT K.. IS METFONNIN THERAPY FOR POLYCYSTIC OVARY SYNDROME SAFE DURING PREGNANCY?. BASIC CLINICAL PHARMACOLOGY AND TOXICOLOGY[Internet]. 2005;96(6):410-412. Available from: https://sid.ir/paper/655843/en
IEEE:
CopyB. BROCK, and K. SMIDT, “IS METFONNIN THERAPY FOR POLYCYSTIC OVARY SYNDROME SAFE DURING PREGNANCY?,” BASIC CLINICAL PHARMACOLOGY AND TOXICOLOGY, vol. 96, no. 6, pp. 410–412, 2005, [Online]. Available: https://sid.ir/paper/655843/en